Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 1,423.40
+27.20 (1.95%)
Feb 18, 2026, 1:40 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 226.87 billion as of February 17, 2026. Its market cap has increased by 5.35% in one year.
Market Cap
226.87B
Enterprise Value
244.74B
Revenue
31.93B
Ranking
n/a
PE Ratio
1,031.23
Stock Price
1,423.40
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 226.87B, an increase of 1,203.58%. That is a compound annual growth rate of 10.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 226.87B | -3.46% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 545.58B |
| Ipca Laboratories | 376.85B |
| Ajanta Pharma | 364.68B |
| Gland Pharma | 293.40B |
| Emcure Pharmaceuticals | 282.22B |
| Piramal Pharma | 220.36B |
| Eris Lifesciences | 195.93B |
| Alembic Pharmaceuticals | 151.33B |